Clinical trials
Post Transplant Diabetes Mellitus clinical trials
Below are recruiting post transplant diabetes mellitus clinical trials, each written for real people, not researchers. We’re tracking 19 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06440330Recruiting
Predicting diabetes after kidney transplant study
This study looks for factors that may help predict who will develop diabetes after a kidney transplant. It is for people who have not had diabetes before their transplant and are starting on tacrolimus and steroids.
Edegem, AntwerpenAges 18 years+ - NCT06962410Recruiting
Hybrid Closed-Loop for Diabetes After Kidney Transplant
This trial tests a hybrid closed-loop system (an advanced insulin pump that automatically adjusts insulin) for people with diabetes who have had a kidney transplant. It may help improve blood sugar control and reduce the burden of managing diabetes after transplant.
Taiyuan, ShanxiAges 18–70 - NCT06046833Recruiting
Continuous glucose monitoring for diabetic gastroparesis
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar in people with diabetes and gastroparesis (slow stomach emptying). If you have type 1 or type 2 diabetes and stomach symptoms, this could help doctors better understand your glucose patterns.
Cleveland, OhioAges 18 years+ - NCT06688331RecruitingPhase 2
Treating early stage 1 type 1 diabetes in children with cell therapy and antibody
This trial tests a new combination treatment for children who have been diagnosed with stage 1 type 1 diabetes, meaning they have some markers but do not yet need insulin. The treatment uses special immune cells (Treg cells) and an antibody (anti-CD20) to try to preserve the body's ability to make insulin.
BialystokAges 3–18 - NCT06095492Recruiting
Comparing diabetes drugs after kidney transplant
This trial tests two diabetes medications, empagliflozin and linagliptin, to see which one works better for controlling blood sugar, protecting kidney function, and improving body composition in people who have had a kidney transplant and have diabetes.
Gurgaon, HaryanaAges 30 years+ - NCT07503028Enrolling by invitationEarly Phase 1
Stem cell therapy for severe low blood sugar in diabetes
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
Hefei, AnhuiAges 18–70 - NCT05576116Enrolling by invitation
Bariatric surgery plus pancreas transplant after kidney transplant
This trial studies whether adding bariatric (weight-loss) surgery and a pancreas transplant can improve health in people with long-term type 2 diabetes who already received a kidney transplant. It may help with blood sugar control and related metabolic health, while also needing careful safety screening for kidney function and blood vessel health.
Toronto, OntarioAges 18–50 - NCT01241864RecruitingPhase 2
Islet transplant for type 1 diabetes after kidney transplant
This trial tests whether transplanting insulin-producing “islet” cells can better control blood sugar in people who have already received a kidney transplant. It’s mainly for adults with type 1 diabetes whose body is no longer making enough insulin, while they are on kidney-transplant medicines.
Chicago, IllinoisAges 18–68 - NCT05195944Enrolling by invitationPhase 4
Semaglutide versus sitagliptin after liver transplant for diabetes
This trial compares two diabetes medicines—semaglutide and sitagliptin—in people who have had a liver transplant and have type 2 diabetes (or diabetes after transplant). It’s looking to see which medicine works better and is safe for blood sugar control in the transplant setting.
Toronto, OntarioAges 18 years+ - NCT03746769RecruitingPhase 1/Phase 2
Testing gastrin to improve results of islet cell transplant
This trial looks at whether adding gastrin can improve outcomes after an islet cell transplant for people with type 1 diabetes. It may help some participants achieve better blood sugar control, but it also requires close follow-up and immune-suppressing medications to protect the new cells.
Duarte, CaliforniaAges 18–68 - NCT06937294RecruitingPhase 4
Metformin for diabetes from chronic pancreatitis
This trial tests if metformin is safe and effective for people who developed diabetes after being diagnosed with chronic pancreatitis. You must not have taken any diabetes medication before.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT04672863Recruiting
Mediterranean diet after a first liver transplant
This study tests whether eating a Mediterranean-style diet after a first liver transplant is safe and helpful for recovery or health. It targets adults who are able to follow a nutrition plan and do not have certain complications or conditions that could interfere with diet changes.
Rochester, MinnesotaAges 18 years+ - NCT02817360RecruitingPhase 4
Preventing heart events in people with type 2 diabetes
This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.
Mödling, Lower AustriaAges 18 years+ - NCT06191094Enrolling by invitationPhase 4
Vabysmo before eye surgery for bleeding in diabetes
This trial tests if an injection of Vabysmo (faricimab) given before surgery can help people with eye bleeding from diabetic retinopathy. It aims to reduce blood in the eye and improve surgery outcomes.
Aurora, ColoradoAges 18 years+ - NCT06932874RecruitingPhase 4
Metformin for diabetes with heart disease
This trial tests a long-acting metformin pill in people with both type 2 diabetes and coronary heart disease. It aims to see if metformin can safely help control blood sugar in this specific group.
Beijing, Beijing MunicipalityAges 30–75 - NCT06474598RecruitingPhase 2
Test of MTX228 for type 1 diabetes with some insulin
This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.
Edmonton, AlbertaAges 18–65 - NCT06496412Recruiting
Fecal transplant for brain health in type 1 diabetes
This trial tests whether transplanting healthy bacteria into your gut can improve memory and thinking skills in people with long-term type 1 diabetes. If you have had type 1 diabetes for 10 years or more, this study may help find a new way to protect your brain.
Changsha, HunanAges 18–60 - NCT06140537RecruitingPhase 4
Dapagliflozin for kidney and heart health after transplant
This study tests whether a diabetes drug called dapagliflozin (Farxiga) can help protect your kidney function and heart health after a kidney transplant. It's for people who have had a transplant for at least a year and have diabetes or post-transplant diabetes.
Aurora, ColoradoAges 18–80 - NCT06790537RecruitingPhase 4
Pregabalin for itching in diabetes: a controlled study
This trial tests if pregabalin can reduce chronic itching in people with type 2 diabetes. It compares pregabalin against a placebo (inactive pill) to see if itching improves more with the active drug.
Chandigarh, ChandigarhAges 18 years+
Hear when a new Post Transplant Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for post transplant diabetes mellitus?
- Yes. Clin2 currently lists 19 recruiting post transplant diabetes mellitus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a post transplant diabetes mellitus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a post transplant diabetes mellitus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.